Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13823Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Roy, Aniruddha | - |
| dc.date.accessioned | 2024-01-11T10:09:24Z | - |
| dc.date.available | 2024-01-11T10:09:24Z | - |
| dc.date.issued | 2012-05 | - |
| dc.identifier.uri | https://link.springer.com/article/10.1007/s11095-012-0756-y | - |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13823 | - |
| dc.description.abstract | Cancer is a multifactorial syndrome; hence, multidimensional therapy with a chemo-immunotherapeutic conjugate could be more effective in curing the disease. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Paclitaxel (PTX) | en_US |
| dc.subject | Cancer | en_US |
| dc.title | Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of lps for combined chemo-immunotherapy | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Department of Pharmacy | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.